Preferences for adjuvant immunotherapy in patients with resected stage III melanoma: A discrete choice experiment.
Version 4 2025-06-02, 04:31
Version 3 2024-06-19, 17:51
Version 2 2024-06-06, 05:21
Version 1 2023-06-07, 01:47
journal contribution
posted on 2025-06-02, 04:31 authored by Ann LivingstoneAnn Livingstone, Alexander M Menzies, Kirsten Howard, Martin R Stockler, Rachael L MortonPreferences for adjuvant immunotherapy in patients with resected stage III melanoma: A discrete choice experiment.
